Article: Drug for Lou Gehrig's disease held effective

In what could be the first ray of hope for people with a devastating fatal disease, French researchers report in today's issue of the New England Journal of Medicine that an experimental drug called riluzole doubled the survival time of some patients with Lou Gehrig's disease.

Amyotrophic lateral sclerosis -- better known as Lou Gehrig's disease, after the Yankees first baseman who died of it in 1941 -- is a crippling nerve disorder that causes progressive muscle weakness, including the muscles for breathing and swallowing.

The cause of ALS -- which kills 1 in 800 men and 1 in 1,200 women -- is not clear, although researchers believe it may result from an autoimmune problem in which a ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!